Showing results (1471-1480 of 30,442) with videos related to

Sort By:
Pageof 3,045
Frontiers in Pharmacology|February 28, 2018
Usage of Mitogen-Activated Protein Kinase Small Molecule Inhibitors: More Than Just Inhibition!Steffen K Meurer, Ralf Weiskirchen
Frontiers in Pharmacology|February 28, 2018
Corrigendum: From Resistance to Sensitivity: Insights and Implications of Biphasic Modulation of Autophagy by SunitinibAmal Kamal Abdel-Aziz, Ashraf B Abdel-Naim, Samia Shouman, et al.
Frontiers in Pharmacology|March 1, 2018
Facile Fabrication of Reduction-Responsive Supramolecular Nanoassemblies for Co-delivery of Doxorubicin and Sorafenib toward Hepatoma CellsQingqing Xiong, Mangmang Cui, Ge Yu, et al.
Frontiers in Pharmacology|March 1, 2018
The Association of Unfavorable Traffic Events and Cannabis Usage: A Meta-AnalysisSorin Hostiuc, Alin Moldoveanu, Ionuţ Negoi, et al.
Frontiers in Pharmacology|March 2, 2018
Inhibition of Protein Glycation by Tiger Milk Mushroom [Lignosus rhinocerus (Cooke) Ryvarden] and Search for Potential Anti-diabetic Activity-Related Metabolic Pathways by Genomic and Transcriptomic Data MiningHui-Yeng Y Yap, Nget-Hong Tan, Szu-Ting Ng, et al.
Frontiers in Pharmacology|December 4, 2018
c-Abl Inhibition Exerts Symptomatic Antiparkinsonian Effects Through a Striatal Postsynaptic MechanismYu Zhou, Yukio Yamamura, Masatoshi Ogawa, et al.
Frontiers in Pharmacology|March 22, 2018
QSAR-Driven Design and Discovery of Novel Compounds With Antiplasmodial and Transmission Blocking ActivitiesMarilia N N Lima, Cleber C Melo-Filho, Gustavo C Cassiano, et al.
Frontiers in Pharmacology|March 22, 2018
Vortioxetine Treatment Reverses Subchronic PCP Treatment-Induced Cognitive Impairments: A Potential Role for Serotonin Receptor-Mediated Regulation of GABA NeurotransmissionAlan L Pehrson, Christian S Pedersen, Kirstine Sloth Tølbøl, et al.
Frontiers in Pharmacology|March 23, 2018
The Metabotropic Purinergic P2Y Receptor Family as Novel Drug Target in EpilepsyMariana Alves, Edward Beamer, Tobias Engel
Frontiers in Pharmacology|November 29, 2018
Biodegradable Nanoparticles Mediated Co-delivery of Erlotinib (ELTN) and Fedratinib (FDTN) Toward the Treatment of ELTN-Resistant Non-small Cell Lung Cancer (NSCLC) via Suppression of the JAK2/STAT3 Signaling PathwayDonglai Chen, Fuquan Zhang, Jinhui Wang, et al.
Pageof 3,045